XML 21 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 03, 2021
Jun. 27, 2020
Jul. 03, 2021
Jun. 27, 2020
Jan. 02, 2021
Operating activities:          
Net income (loss) $ 128,676 $ 161,181 $ (134,586) $ 153,307  
Adjustments to reconcile net income (loss) to net cash from operating activities:          
Depreciation     43,565 45,399  
Amortization of acquisition intangibles     10,978 12,199  
Other amortization     5,814 5,107  
Impairment of intangible assets and goodwill     163,047 20,319  
Loss on classification of assets held for sale 9,828 0 236,180 0  
Amortization of debt issuance costs     7,669 5,119  
Other     (14,224) 16,247  
Changes in assets and liabilities:          
Accounts receivable     (200,106) (392,134)  
Inventories     (175,149) (61,409)  
Other assets     4,451 (31,570)  
Accounts payable     300,318 210,338  
Accrued pension and postretirement benefits     (39,176) (19,318)  
Accrued liabilities and other     3,475 18,603  
Net cash from operating activities     212,256 (17,793)  
Investing activities:          
Capital expenditures     (25,331) (46,512)  
Proceeds from sales of assets     2,455 66  
Other     6,937 5,823  
Net cash from investing activities     (15,939) (40,623)  
Financing activities:          
Repayments on Term Loan Facilities     (306,250) 0  
Borrowings on Accounts Receivable Securitization Facility     0 227,061  
Repayments on Accounts Receivable Securitization Facility     0 (227,061)  
Borrowings on Revolving Loan Facilities     0 1,638,000  
Repayments on Revolving Loan Facilities     0 (1,638,000)  
Borrowings on Senior Notes     0 700,000  
Borrowings on International Debt     0 31,222  
Borrowings on notes payable     42,638 116,669  
Repayments on notes payable     (43,066) (112,373)  
Share repurchases     0 (200,269)  
Cash dividends paid     (104,719) (105,896)  
Other     (2,524) (14,035)  
Net cash from financing activities     (413,921) 415,318  
Effect of changes in foreign exchange rates on cash     (16,780) (2,669)  
Change in cash, cash equivalents and restricted cash     (234,384) 354,233  
Cash, cash equivalents and restricted cash at beginning of year     910,603 329,923 $ 329,923
Cash, cash equivalents and restricted cash at end of period 676,219 684,156 676,219 684,156 910,603
Less restricted cash at end of period 0 1,042 0 1,042  
Cash and cash equivalents at end of period 676,219 683,114 676,219 683,114  
Balances included in the Condensed Consolidated Balance Sheets [Abstract]          
Cash and cash equivalents 667,298 556,099 667,298 556,099 900,615
Cash and cash equivalents, included in current assets of discontinued operations 8,921 127,015 8,921 127,015 8,822
Cash and cash equivalents at end of period $ 676,219 $ 683,114 676,219 683,114  
Supplemental Cash Flow Information [Abstract]          
Capital expenditures included in accounts payable at end of period     11,477   $ 17,931
Right-of-Use assets obtained in exchange for lease obligations     $ 37,725 $ 23,769